The FDA has received 4,053 adverse event reports for cats that name Bexagliflozin.
- 4,053 reports name Bexagliflozin in cats, which is 2.7% of all 151,164 cat reports. A report counts under every active ingredient it names.
- 22% are marked serious and 7.8% record a death or euthanasia; across all cat reports those figures are 27% and 9.4%.
- 15% are complaints that the product did not work (19% across all cat reports).
- The clinical signs reported most are ketosis, weight loss and hyperglycaemia.
- The FDA lists 1 approved animal drug application containing Bexagliflozin for cats, the earliest approved in 2022.
- None of this is a rate. The FDA data does not record how many cats were given Bexagliflozin, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All cat reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 880 | 22% | 27% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 318 | 7.8% | 9.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 600 | 15% | 19% |
| Seizurea seizure or convulsion is among the clinical signs | 20 | 0.5% | 2.6% |
| Not used per labelthe report says the product was not used the way its label directs | 543 | 13% | 33% |
Where on the body do the reported signs sit?
Not on the body: Whole body 6.7% Did not work 5.7%
- Blood and organ tests47%ketosis, hyperglycaemia, hypoglycaemia, other abnormal test result and 7 more
- Stomach and gut32%weight loss, diarrhoea, vomiting, not eating and 3 more
- Whole body6.7%lethargy, death by euthanasia
- Thirst and urination6.7%dehydration, polyuria, polydipsia
- Did not work5.7%lack of efficacy
- Behaviour2.0%behavioural disorder
Each figure is a share of sign mentions among the 25 signs reported most for Bexagliflozin in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Ketosis1,483 37%
- Weight loss1,090 27%
- Hyperglycaemia911 22%
- Diarrhoea762 19%
- Lack of efficacy594 15%
- Vomiting450 11%
- Lethargy445 11%
- Hypoglycaemia431 11%
Reports received per year
Is it approved for cats?
The FDA lists 1 approved animal drug application containing Bexagliflozin for cats, the earliest approved in 2022.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| BexacatElanco US Inc. | Tablet RX | Cat | 2022 | 141-566 |
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Ketamine in cats4,012
- Eprinomectin in cats3,856
- Maropitant in cats3,847
- Meloxicam in cats3,654
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.